BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 9323748)

  • 41. Prescribing of psychotropic drugs and indicators for use in residential aged care and residents with dementia.
    Brimelow RE; Wollin JA; Byrne GJ; Dissanayaka NN
    Int Psychogeriatr; 2019 Jun; 31(6):837-847. PubMed ID: 30457077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of psychotropic medicines in residential care facilities for older people in Hawke's Bay, New Zealand.
    Tucker M; Hosford I
    N Z Med J; 2008 May; 121(1274):18-25. PubMed ID: 18535643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland.
    Gobert M; D'hoore W
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):712-21. PubMed ID: 16035123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychotropic medications for elders in residential care.
    Croucher M
    N Z Med J; 2008 May; 121(1274):7-9. PubMed ID: 18535640
    [No Abstract]   [Full Text] [Related]  

  • 45. "Just say no!": the right to refuse psychotropic medication in long-term care facilities.
    Smith GP
    Ann Health Law; 2004; 13(1):1-35, table of contents. PubMed ID: 15002180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education.
    Ray WA; Taylor JA; Meador KG; Lichtenstein MJ; Griffin MR; Fought R; Adams ML; Blazer DG
    Arch Intern Med; 1993 Mar; 153(6):713-21. PubMed ID: 8447709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.
    Nørgaard A; Jensen-Dahm C; Gasse C; Hansen ES; Waldemar G
    J Alzheimers Dis; 2017; 56(2):707-716. PubMed ID: 28035931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Gerontopsychiatric competence is in demand. The current psychopharmacologic treatment practice in homes for the aged and nursing homes].
    Riedel-Heller SG; Stelzner G; Schork A; Angermeyer MC
    Psychiatr Prax; 1999 Nov; 26(6):273-6. PubMed ID: 10627955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nursing homes and fall in the consumption of psychotropic medications].
    Giet R; Bonet C
    Soins Gerontol; 2017; 22(127):25-29. PubMed ID: 28917333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries.
    Snowdon J; Galanos D; Vaswani D
    Int Psychogeriatr; 2011 Nov; 23(9):1520-5. PubMed ID: 21429281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychotropic drug use in Sydney nursing homes.
    Snowdon J; Vaughan R; Miller R; Burgess EE; Tremlett P
    Med J Aust; 1995 Jul; 163(2):70-2. PubMed ID: 7616901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Geriatric drug utilisation of psychotropics in Belgian nursing homes.
    Azermai M; Elseviers M; Petrovic M; Van Bortel L; Vander Stichele R
    Hum Psychopharmacol; 2011 Jan; 26(1):12-20. PubMed ID: 21394786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes between 1982 and 2000 in the prevalence of behavioral symptoms and psychotropic drug treatment among old people with cognitive impairment in geriatric care.
    Lövheim H; Sandman PO; Karlsson S; Gustafson Y
    Int Psychogeriatr; 2009 Oct; 21(5):941-8. PubMed ID: 19586566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective.
    Hughes CM; Lapane KL; Mor V; Ikegami N; Jónsson PV; Ljunggren G; Sgadari A
    J Am Geriatr Soc; 2000 Aug; 48(8):931-7. PubMed ID: 10968297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence, Patterns and Predictors of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson's Disease In Long Term Care Settings In The United States.
    Bhattacharjee S; Goldstone L; Warholak T
    J Parkinsons Dis; 2016; 6(1):247-55. PubMed ID: 26756742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The need for a more rational approach to drug prescribing for elderly people in nursing homes.
    Nolan L; O'Malley K
    Age Ageing; 1989 Jan; 18(1):52-6. PubMed ID: 2711922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does the context matter? Utilization of sedative drugs in nursing homes--a multilevel analysis.
    Sonntag A; Matschinger H; Angermeyer MC; Riedel-Heller SG
    Pharmacopsychiatry; 2006 Jul; 39(4):142-9. PubMed ID: 16871469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New rules for prescribing psychotropics in nursing homes.
    Smith DA
    Geriatrics; 1990 Feb; 45(2):44-56. PubMed ID: 2404833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.
    Jacquin-Piques A; Sacco G; Tavassoli N; Rouaud O; Bejot Y; Giroud M; Robert P; Vellas B; Bonin-Guillaume S
    J Alzheimers Dis; 2016; 49(3):671-80. PubMed ID: 26484903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. OBRA--its effect on the mentally ill in South Dakota nursing homes.
    Smith DA; Jensen S
    S D J Med; 1990 Jun; 43(6):13-4. PubMed ID: 2399453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.